Recent Finacing
Recent Raise
EnPlusOne Biosciences develops ezRNA™, an enzymatic, template-free aqueous RNA synthesis platform that produces long (>100 nt) and modified oligonucleotides for siRNA, ASO, gRNA, mRNA, and GMP manufacturing.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
See the team members at EnPlusOne Biosciences.
